T. Rowe Price Associates’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.38M | Buy |
|
|||||
|
2025
Q2 | $1.06M | Buy |
|
|||||
|
2025
Q1 | $1.06M | Buy |
|
|||||
|
2024
Q4 | $771K | Buy |
|
|||||
|
2024
Q3 | $729K | Buy |
|
|||||
|
2024
Q2 | $547K | Buy |
|
|||||
|
2024
Q1 | $493K | Buy |
|
|||||
|
2023
Q4 | $463K | Buy |
|
|||||
|
2023
Q3 | $313K | Buy |
|
|||||
|
2023
Q2 | $223K | Buy |
|
|||||
|
2023
Q1 | $28K | Buy |
|
|||||
|
2022
Q4 | $35K | Buy |
|
|||||
|
2022
Q3 | $35K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $32.7M | Sell |
|
|||||
|
2019
Q2 | $134M | Sell |
|
|||||
|
2019
Q1 | $281M | Buy |
|
|||||
|
2018
Q4 | $265M | Buy |
|
|||||
|
2018
Q3 | $246M | Buy |
|
|||||
|
2018
Q2 | $712K | Buy |
|